Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 2
2007 3
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

6 results
Results by year
Filters applied: . Clear all
Page 1
The DONPAD-study--treatment of dementia in patients with Parkinson's disease with donepezil.
Müller T, Welnic J, Fuchs G, Baas H, Ebersbach G, Reichmann H. Müller T, et al. Among authors: welnic j. J Neural Transm Suppl. 2006;(71):27-30. doi: 10.1007/978-3-211-33328-0_3. J Neural Transm Suppl. 2006. PMID: 17447412 Clinical Trial.
Impact of levodopa on reduced nerve growth factor levels in patients with Parkinson disease.
Müller T, Lang UE, Muhlack S, Welnic J, Hellweg R. Müller T, et al. Among authors: welnic j. Clin Neuropharmacol. 2005 Sep-Oct;28(5):238-40. doi: 10.1097/01.wnf.0000183447.58529.79. Clin Neuropharmacol. 2005. PMID: 16239764 Clinical Trial.
Acute levodopa administration reduces cortisol release in patients with Parkinson's disease.
Müller T, Welnic J, Muhlack S. Müller T, et al. Among authors: welnic j. J Neural Transm (Vienna). 2007 Mar;114(3):347-50. doi: 10.1007/s00702-006-0552-0. Epub 2006 Aug 24. J Neural Transm (Vienna). 2007. PMID: 16932991 Clinical Trial.
Endurance exercise modulates levodopa induced growth hormone release in patients with Parkinson's disease.
Müller T, Welnic J, Woitalla D, Muhlack S. Müller T, et al. Among authors: welnic j. Neurosci Lett. 2007 Jul 11;422(2):119-22. doi: 10.1016/j.neulet.2007.06.008. Epub 2007 Jun 8. Neurosci Lett. 2007. PMID: 17590511
Exercise improves efficacy of levodopa in patients with Parkinson's disease.
Muhlack S, Welnic J, Woitalla D, Müller T. Muhlack S, et al. Among authors: welnic j. Mov Disord. 2007 Feb 15;22(3):427-30. doi: 10.1002/mds.21346. Mov Disord. 2007. PMID: 17226855
Chronic levodopa intake increases levodopa plasma bioavailability in patients with Parkinson's disease.
Muhlack S, Woitalla D, Welnic J, Twiehaus S, Przuntek H, Müller T. Muhlack S, et al. Among authors: welnic j. Neurosci Lett. 2004 Jun 17;363(3):284-7. doi: 10.1016/j.neulet.2004.04.012. Neurosci Lett. 2004. PMID: 15182961 Clinical Trial.
Feedback